Mark Austin
Direttore Finanziario/CFO presso PERSPECTIVE THERAPEUTICS, INC.
Patrimonio netto: 134 448 $ in data 30/04/2024
Posizioni attive di Mark Austin
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| PERSPECTIVE THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 01/07/2017 | - |
| Direttore Finanziario/CFO | 01/07/2017 | - | |
| Segretario Aziendale | 15/09/2020 | - |
Storia della carriera di Mark Austin
Precedenti posizioni note di Mark Austin
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
KPMG Advisory SP ZOO Spolka Komandytowa
 KPMG Advisory SP ZOO Spolka Komandytowa Investment ManagersFinance Part of KPMG CEE Holdings Ltd., KPMG Advisory Sp zoo Spolka Komandytowa provides financial advisory services. The company is based in Warsaw, Poland. | Corporate Officer/Principal | 01/01/2009 | 01/07/2017 |
IsoRay, Inc.
 IsoRay, Inc. Medical SpecialtiesHealth Technology IsoRay, Inc. is a medical technology company, which engages in the development, manufacture, and sale of isotope-based medical products and devices. The firm focuses on the treatment of cancer and other malignant diseases. Its core product is Cesium-131, a radioisotope for the treatment of malignant tumors. The company was founded by Lance A. Bray in 1983 and is headquartered in Richland, WA. | Comptroller/Controller/Auditor | 24/07/2017 | - |
| Direttore Finanziario/CFO | 24/07/2017 | - | |
| Segretario Aziendale | 03/12/2018 | - |
Formazione di Mark Austin
| Santa Clara University | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 3 |
| Polonia | 2 |
| 2 |
Posizioni
| Comptroller/Controller/Auditor | 2 |
| Director of Finance/CFO | 2 |
| Corporate Secretary | 2 |
Settori
| Health Technology | 2 |
| Consumer Services | 2 |
| Finance | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 3 |
|---|---|
IsoRay, Inc.
IsoRay, Inc. Medical SpecialtiesHealth Technology IsoRay, Inc. is a medical technology company, which engages in the development, manufacture, and sale of isotope-based medical products and devices. The firm focuses on the treatment of cancer and other malignant diseases. Its core product is Cesium-131, a radioisotope for the treatment of malignant tumors. The company was founded by Lance A. Bray in 1983 and is headquartered in Richland, WA. | Health Technology |
KPMG Advisory SP ZOO Spolka Komandytowa
KPMG Advisory SP ZOO Spolka Komandytowa Investment ManagersFinance Part of KPMG CEE Holdings Ltd., KPMG Advisory Sp zoo Spolka Komandytowa provides financial advisory services. The company is based in Warsaw, Poland. | Finance |
| Perspective Therapeutics, Inc. |
- Borsa valori
- Insiders
- Mark Austin
- Esperienza
